Key facts
- Iterative Health’s last known valuation is $1.4B (Feb 2026).
- It has raised $271.1M; the latest was Later Stage VC ($75.0M) in Feb 2026.
- Notable investors include Plug and Play Tech Center, Alumni Ventures, MedTech Innovator, Insight Partners (New York), Texas Medical Center — 34 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 34 names
- ·Watchlist + deal alerts for Iterative Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Iterative Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Iterative Health
Developer of a clinical research site network designed to speed up gastroenterology studies. The company offers a platform powered by artificial intelligence, broad site access and efficient patient recruitment, enabling pharmaceutical and biotechnology companies to complete trials more quickly than usual.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2017
- Employees
- 144
- Website
- iterative.health/
- Ownership
- Privately Held (backing)
Iterative Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Iterative Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Iterative Health in its N-PORT filings yet. We sweep new filings monthly.